LexDanaLexDanabeta
Inventor

Tao Jiang

Inventor
San Diego, CA, US

Overview

55→
Patents
1999–2019
Patent span
Chemistry
Primary field (CPC C)

Patents· 55 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes15%
C07KPeptides8%
Y02PClimate change mitigation technologies in the production or processing of goods6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07CAcyclic or carbocyclic compounds1%
C08BPolysaccharides1%
PatentTitleYear
10,259,845Peptides whose uptake by cells is controllable20199,808,532'Peptides whose uptake in cells is controllable'20179,695,251'Activatable cell penetrating peptides with quenched fluorophores'20179,682,151'Peptides whose uptake in cells is controllable'20179,499,556'Convenient preparation of N-substituted morphinan-6-ols from morphinan-6-ones'20169,321,809'Macrocyclic compounds for suppressing replication of hepatitis C virus'20169,193,737'Production of 6-hydroxy morphinans without the isolation of intermediates'20159,072,792'Peptides whose uptake by cells is controllable'20159,040,705'Preparation of saturated ketone morphinan compounds'20159,012,468'One pot process for producing 6-hydroxyl nal-opiate'20158,957,081'Compounds and compositions as protein kinase inhibitors'20158,729,266'Preparation of N-alkylated opiates by reductive amination'20148,642,545'Erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereof'20148,642,561'Peptides whose uptake by cells is controllable'20148,629,104'G-CSF and water-soluble polymer conjugate'20148,624,031'Production of alkaloids without the isolation of intermediates'20148,624,030'N-demethylation of 6-keto morphinans'20148,614,224'Sinomenine derivatives and processes for their synthesis'20138,592,432'Compounds and compositions as protein kinase inhibitors'20138,563,725'Preparation of saturated ketone morphinan compounds having low metal content'20138,524,904'Process for the preparation of 6-alpha-hydroxy-N-alkylated opiates'20138,518,931'Compounds and compositions as kinase inhibitors'20138,461,337'Sinomenine derivatives and processes for their synthesis'20138,399,450'Compounds and compositions as protein kinase inhibitors'20138,372,858'Compounds and compositions as protein kinase inhibitors'20138,367,827'Process for preparing hydrocodone using a super acid'20138,309,727'Opiate reduction utilizing catalytic hydrogen transfer reaction'20128,293,907'Preparation of saturated ketone morphinan compounds by catalytic isomerization'20128,273,888'Process for the preparation of 6-alpha-hydroxy-N-alkylated opiates'20128,252,808'Process and compounds for the production of (+)opiates'20128,252,928'Processes for the synthesis of five and six membered heterocyclic rings'20128,217,175'Preparation of oxymorphone from oripavine'20128,202,971'Process for preparing compounds of chitosan saccharified with aminosugar'20128,168,790'Process for the preparation of 6-beta hydroxy morphinan compounds'20128,148,528'Processes and compounds for the preparation of normorphinans'20128,110,554'Peptides whose uptake by cells is controllable'20128,101,757'Processes for the preparation of normorphinan salts'20128,080,661'Processes for the synthesis of tertiary amines'20118,067,596'Processes for the production of (+)- “Nal” morphinan compounds'20118,017,777'Process for the preparation of buprenorphine and derivatives for buprenorphine'20117,999,105'Process for the preparation of 3-hydroxymorphinan derivatives'20117,985,858'Process for the preparation of 6-alpha-hydroxy-N-alkylated opiates'20117,985,401'Peptides whose uptake by cells is controllable'20117,968,557'Substituted pyrrolo[2,3-2]pyrimidines as protein kinase inhibitors'20117,750,021'Immunosuppressant compounds and compositions'20107,671,204'N-demethylation of N-methyl morphinans'20107,601,742'Pyrrolidones with anti-HIV activity'20097,495,016'Pyrrolidones with anti-HIV activity'20097,431,915'Peptides whose uptake by cells is controllable'20087,417,065'Immunosuppressant compounds and compositions'20087,205,328'Oxindoles with anti-HIV activity'20077,060,697'Immunosuppressant compounds and compositions'20067,019,141'Quinolones with anti-HIV activity'20066,965,033'Bisamidate phosphonate prodrugs'20055,955,453'Membrane-permeant phosphoinositides'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2017Based in San Diego, CA, US· patent location history
2010–2014Based in St. Louis, MO, US· patent location history
2011–2017Patents assigned to JIANG TAO (34)· patent assignee history
2011–2016Patents assigned to MALLINCKRODT LLC (23)· patent assignee history
2011–2015Patents assigned to WANG PETER X (18)· patent assignee history
2011–2014Patents assigned to CANTRELL GARY L (12)· patent assignee history
2011–2014Patents assigned to BERBERICH DAVID W (11)· patent assignee history
2012–2016Based in Chesterfield, MO, US· patent location history
2014Based in Jiangsu, CN· patent location history
2015–2019Based in Rancho Santa Fe, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JIANG TAOself342011–2017
MALLINCKRODT LLC232011–2016
WANG PETER X182011–2015
CANTRELL GARY L122011–2014
BERBERICH DAVID W112011–2014
Locations
LocationPatentsSpan
San Diego, California, US221999–2017
St. Louis, MO, US192010–2014
Chesterfield, MO, US82012–2016
Rancho Santa Fe, California, US22015–2019
Jiangsu, CN22014